BioFishency raised €2.1M in a funding round in Jan 2019. The company is based in Israel. Investors in the round: Aqua Spark, Trendlines Group. Data as of 22 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
